Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth.
Boreddy SR, Nair R, Pandey PK, Kuriakose A, Marigowda SB, Dey C, Banerjee A, Kulkarni H, Sagar M, Krishn SR, Rao S, Ar M, Tiwari V, Alke B, Mv PK, Shri M, Dhamne C, Patel S, Sharma P, Periyasamy S, Bhatnagar J, Kuriakose MA, Reddy RB, Suresh A, Sreenivas S, Govindappa N, Moole PR, Bughani U, Tan SL, Nair P. Boreddy SR, et al. Among authors: nair p, nair r. Cancer Res. 2023 Jun 2;83(11):1883-1904. doi: 10.1158/0008-5472.CAN-21-4425. Cancer Res. 2023. PMID: 37074042 Free PMC article.
T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab.
Bughani U, Saha A, Kuriakose A, Nair R, Sadashivarao RB, Venkataraman R, Patel S, Deshchougule AT, S SK, Montero E, Pai HV, Palanivelu DV, Melarkode R, Nair P. Bughani U, et al. Among authors: nair p, nair r. PLoS One. 2017 Jul 3;12(7):e0180088. doi: 10.1371/journal.pone.0180088. eCollection 2017. PLoS One. 2017. PMID: 28672038 Free PMC article.
Correction: T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab.
Bughani U, Saha A, Kuriakose A, Nair R, Sadashivarao RB, Venkataraman R, Patel S, Tushar Deshchougule A, Satish KS, Montero E, Pai HV, Palanivelu DV, Melarkode R, Nair P. Bughani U, et al. Among authors: nair p, nair r. PLoS One. 2018 Jan 30;13(1):e0192335. doi: 10.1371/journal.pone.0192335. eCollection 2018. PLoS One. 2018. PMID: 29381749 Free PMC article.
Analytical similarity assessment of MYL-1402O to reference Bevacizumab.
Goyal P, Vats B, Subbarao M, Honnappa CG, Kabadi P, Rohil S, Bera A, Mehta GR, Pai H, Adhikari L, Tagore R, Sharma S, Venkatachala R, Nair P, Annegowda S, Sahu A, Trivedi S, Shastri N, Gokhale Y, Thomas R, Thakur A, Mohan D, Rao K U, Melarkode R, Ullanat R. Goyal P, et al. Among authors: nair p. Expert Opin Biol Ther. 2022 Feb;22(2):271-298. doi: 10.1080/14712598.2021.1973426. Epub 2021 Oct 13. Expert Opin Biol Ther. 2022. PMID: 34465264
Endoscopic Endonasal Inter-dural Posterior Clinoidectomy and Pituitary Hemitranspostion for Surgical Resection of a Large Suprasellar Ependymoma Involving the Inter-peduncular Cistern.
Patel BK, Gowda A, Darshan HR, Binu A, Sudhir BJ, Easwer HV, Krishnakumar K, Nair P. Patel BK, et al. Among authors: nair p. Neurol India. 2024 Mar 1;72(2):261-265. doi: 10.4103/neurol-india.Neurol-India-D-24-00115. Epub 2024 Apr 30. Neurol India. 2024. PMID: 38817169 No abstract available.
Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial.
Goeldlin MB, Hakim A, Branca M, Abend S, Kneihsl M, Valenzuela Pinilla W, Fenzl S, Rezny-Kasprzak B, Rohner R, Strbian D, Paciaroni M, Thomalla G, Michel P, Nedeltchev K, Gattringer T, Sandset EC, Bonati L, Aguiar de Sousa D, Sylaja PN, Ntaios G, Koga M, Gdovinova Z, Lemmens R, Bornstein NM, Kelly P, Katan M, Horvath T, Dawson J, Fischer U; ELAN Investigators. Goeldlin MB, et al. JAMA Neurol. 2024 May 28:e241450. doi: 10.1001/jamaneurol.2024.1450. Online ahead of print. JAMA Neurol. 2024. PMID: 38805207
2,166 results